Table 2.
Variables (n = 158) | Without dynapenia | With dynapenia | p value |
---|---|---|---|
Age (mean ± SD) | 57.4 ± 13.6 | 66.6 ± 13.3 | < 0.001 |
n (%) | n (%) | ||
Stage of life | 0.002 | ||
Adult | 61 (88.4) | 8 (11.6) | |
Elderly | 60 (67.4) | 29 (32.6) | |
Gender | 0.130 | ||
Male | 58 (71.6) | 23 (28.4) | |
Female | 63 (81.8) | 14 (18.2) | |
Color | 0.027 | ||
Non-white | 77 (82.8) | 16 (17.2) | |
White | 44 (67.7) | 21 (32.2) | |
Tumor location | 0.566 | ||
Lower GIT | 40 (75.5) | 13 (24.5) | |
Attached glands | 28 (7.8) | 11 (28.2) | |
Upper GIT | 20 (74.1) | 7 (25.9) | |
Othersa | 33 (84.6) | 6 (15.4) | |
Length of hospital stay | 0.236 | ||
≤ 7 days | 69 (80.2) | 17 (19.8) | |
> 7 days | 52 (72.2) | 20 (27.8) | |
PG-SGA | 0.308 | ||
Well nourished (A) | 46 (71.9) | 18 (28.1) | |
Moderately malnourished (B) | 53 (82.8) | 11 (17.2) | |
Severely malnourished (C) | 22 (73.3) | 8 (26.7) | |
Cachexia | 0.518 | ||
Yes | 79 (78.2) | 22 (21.8) | |
No | 42 (73.7) | 15 (26.3) |
GIT: gastrointestinal tract. Student’s t-test; aOthers (corresponding to cancers with a low prevalence within the sample): 6.33%: lung and thorax cancer; 3.80%: hematological cancer; 3.16%: skin cancer; 1.89%: cancer of unknown behavior; 1.26%: ovarian cancer; 0.63%: stromal gastrointestinal cancer; 0.63%: bladder cancer; 0.63%: cervical cancer; 0.63%: ganglion cancer; 0.63%: parotid gland cancer; 0.63%: breast cancer; 0.63%: mediastinal cancer; 0.63%: cancer from other locations; 0.63%: peritoneum cancer; 0.63%: pleural cancer; 0.63%: connective tissue cancer; 0.63%: thyroid cancer; 0.63%: submandibular cancer. PG-SGA: Patient-Generated Subjective Global Assessment